nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifabutin—HSP90B1—embryo—testicular cancer	0.0429	0.144	CbGeAlD
Rifabutin—HSP90B1—seminal vesicle—testicular cancer	0.0403	0.135	CbGeAlD
Rifabutin—HSP90AA1—embryo—testicular cancer	0.0314	0.105	CbGeAlD
Rifabutin—HSP90AA1—seminal vesicle—testicular cancer	0.0295	0.0988	CbGeAlD
Rifabutin—HSP90B1—gonad—testicular cancer	0.0291	0.0977	CbGeAlD
Rifabutin—HSP90B1—female gonad—testicular cancer	0.0237	0.0794	CbGeAlD
Rifabutin—HSP90AA1—gonad—testicular cancer	0.0213	0.0714	CbGeAlD
Rifabutin—HSP90B1—testis—testicular cancer	0.021	0.0704	CbGeAlD
Rifabutin—HSP90AA1—female gonad—testicular cancer	0.0173	0.058	CbGeAlD
Rifabutin—HSP90AA1—testis—testicular cancer	0.0154	0.0515	CbGeAlD
Rifabutin—HSP90B1—lymph node—testicular cancer	0.0152	0.051	CbGeAlD
Rifabutin—HSP90AA1—lymph node—testicular cancer	0.0111	0.0373	CbGeAlD
Rifabutin—CYP3A4—Ifosfamide—testicular cancer	0.0106	0.308	CbGbCtD
Rifabutin—CYP1A2—Etoposide—testicular cancer	0.00965	0.281	CbGbCtD
Rifabutin—CYP3A4—Vinblastine—testicular cancer	0.00561	0.163	CbGbCtD
Rifabutin—CYP3A4—Etoposide—testicular cancer	0.00505	0.147	CbGbCtD
Rifabutin—CYP3A4—Doxorubicin—testicular cancer	0.00345	0.1	CbGbCtD
Rifabutin—Chest pain—Ifosfamide—testicular cancer	0.00188	0.00282	CcSEcCtD
Rifabutin—Myalgia—Ifosfamide—testicular cancer	0.00188	0.00282	CcSEcCtD
Rifabutin—Flatulence—Cisplatin—testicular cancer	0.00188	0.00281	CcSEcCtD
Rifabutin—Anorexia—Dactinomycin—testicular cancer	0.00188	0.00281	CcSEcCtD
Rifabutin—Eye disorder—Etoposide—testicular cancer	0.00187	0.00281	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—testicular cancer	0.00187	0.0028	CcSEcCtD
Rifabutin—Blood alkaline phosphatase increased—Epirubicin—testicular cancer	0.00187	0.0028	CcSEcCtD
Rifabutin—Diarrhoea—Chlorambucil—testicular cancer	0.00187	0.0028	CcSEcCtD
Rifabutin—Hypersensitivity—Vinblastine—testicular cancer	0.00184	0.00276	CcSEcCtD
Rifabutin—Decreased appetite—Bleomycin—testicular cancer	0.00184	0.00275	CcSEcCtD
Rifabutin—Confusional state—Ifosfamide—testicular cancer	0.00182	0.00273	CcSEcCtD
Rifabutin—Immune system disorder—Etoposide—testicular cancer	0.00181	0.00272	CcSEcCtD
Rifabutin—Pain—Bleomycin—testicular cancer	0.00181	0.00271	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Dactinomycin—testicular cancer	0.00179	0.00269	CcSEcCtD
Rifabutin—Asthenia—Vinblastine—testicular cancer	0.00179	0.00269	CcSEcCtD
Rifabutin—Thrombocytopenia—Ifosfamide—testicular cancer	0.00177	0.00265	CcSEcCtD
Rifabutin—Anaemia—Cisplatin—testicular cancer	0.00176	0.00264	CcSEcCtD
Rifabutin—Skin disorder—Ifosfamide—testicular cancer	0.00175	0.00263	CcSEcCtD
Rifabutin—Feeling abnormal—Bleomycin—testicular cancer	0.00174	0.00261	CcSEcCtD
Rifabutin—Vomiting—Chlorambucil—testicular cancer	0.00173	0.0026	CcSEcCtD
Rifabutin—Blood alkaline phosphatase increased—Doxorubicin—testicular cancer	0.00173	0.00259	CcSEcCtD
Rifabutin—Anorexia—Ifosfamide—testicular cancer	0.00172	0.00258	CcSEcCtD
Rifabutin—Decreased appetite—Dactinomycin—testicular cancer	0.00171	0.00257	CcSEcCtD
Rifabutin—Diarrhoea—Vinblastine—testicular cancer	0.00171	0.00256	CcSEcCtD
Rifabutin—Dysgeusia—Etoposide—testicular cancer	0.00171	0.00256	CcSEcCtD
Rifabutin—Leukopenia—Cisplatin—testicular cancer	0.00171	0.00256	CcSEcCtD
Rifabutin—Pain—Dactinomycin—testicular cancer	0.00168	0.00252	CcSEcCtD
Rifabutin—Body temperature increased—Bleomycin—testicular cancer	0.00167	0.0025	CcSEcCtD
Rifabutin—Convulsion—Cisplatin—testicular cancer	0.00165	0.00247	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.00164	0.00246	CcSEcCtD
Rifabutin—Myalgia—Cisplatin—testicular cancer	0.00162	0.00243	CcSEcCtD
Rifabutin—Feeling abnormal—Dactinomycin—testicular cancer	0.00162	0.00243	CcSEcCtD
Rifabutin—Nausea—Chlorambucil—testicular cancer	0.00162	0.00243	CcSEcCtD
Rifabutin—Paraesthesia—Ifosfamide—testicular cancer	0.00162	0.00243	CcSEcCtD
Rifabutin—Anaemia—Etoposide—testicular cancer	0.00161	0.00242	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.00161	0.00242	CcSEcCtD
Rifabutin—Gastrointestinal pain—Dactinomycin—testicular cancer	0.00161	0.00241	CcSEcCtD
Rifabutin—Dyspnoea—Ifosfamide—testicular cancer	0.00161	0.00241	CcSEcCtD
Rifabutin—Vomiting—Vinblastine—testicular cancer	0.00159	0.00238	CcSEcCtD
Rifabutin—Decreased appetite—Ifosfamide—testicular cancer	0.00157	0.00235	CcSEcCtD
Rifabutin—Headache—Vinblastine—testicular cancer	0.00157	0.00235	CcSEcCtD
Rifabutin—Leukopenia—Etoposide—testicular cancer	0.00156	0.00234	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.00156	0.00233	CcSEcCtD
Rifabutin—Abdominal pain—Dactinomycin—testicular cancer	0.00156	0.00233	CcSEcCtD
Rifabutin—Body temperature increased—Dactinomycin—testicular cancer	0.00156	0.00233	CcSEcCtD
Rifabutin—Hypersensitivity—Bleomycin—testicular cancer	0.00156	0.00233	CcSEcCtD
Rifabutin—Pain—Ifosfamide—testicular cancer	0.00154	0.00231	CcSEcCtD
Rifabutin—Thrombocytopenia—Cisplatin—testicular cancer	0.00152	0.00228	CcSEcCtD
Rifabutin—Asthenia—Bleomycin—testicular cancer	0.00151	0.00227	CcSEcCtD
Rifabutin—Convulsion—Etoposide—testicular cancer	0.00151	0.00227	CcSEcCtD
Rifabutin—Skin disorder—Cisplatin—testicular cancer	0.00151	0.00226	CcSEcCtD
Rifabutin—Pruritus—Bleomycin—testicular cancer	0.00149	0.00224	CcSEcCtD
Rifabutin—Feeling abnormal—Ifosfamide—testicular cancer	0.00149	0.00223	CcSEcCtD
Rifabutin—Chest pain—Etoposide—testicular cancer	0.00149	0.00223	CcSEcCtD
Rifabutin—Eosinophilia—Methotrexate—testicular cancer	0.00149	0.00223	CcSEcCtD
Rifabutin—Nausea—Vinblastine—testicular cancer	0.00149	0.00223	CcSEcCtD
Rifabutin—Anorexia—Cisplatin—testicular cancer	0.00148	0.00222	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.00148	0.00221	CcSEcCtD
Rifabutin—Gastrointestinal pain—Ifosfamide—testicular cancer	0.00148	0.00221	CcSEcCtD
Rifabutin—Aspartate aminotransferase increased—Epirubicin—testicular cancer	0.00146	0.00219	CcSEcCtD
Rifabutin—Hypersensitivity—Dactinomycin—testicular cancer	0.00145	0.00217	CcSEcCtD
Rifabutin—Confusional state—Etoposide—testicular cancer	0.00144	0.00215	CcSEcCtD
Rifabutin—Alanine aminotransferase increased—Epirubicin—testicular cancer	0.00143	0.00215	CcSEcCtD
Rifabutin—Body temperature increased—Ifosfamide—testicular cancer	0.00143	0.00214	CcSEcCtD
Rifabutin—Abdominal pain—Ifosfamide—testicular cancer	0.00143	0.00214	CcSEcCtD
Rifabutin—Pancytopenia—Methotrexate—testicular cancer	0.00143	0.00214	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.00142	0.00212	CcSEcCtD
Rifabutin—Asthenia—Dactinomycin—testicular cancer	0.00141	0.00212	CcSEcCtD
Rifabutin—Neutropenia—Methotrexate—testicular cancer	0.0014	0.0021	CcSEcCtD
Rifabutin—Paraesthesia—Cisplatin—testicular cancer	0.0014	0.00209	CcSEcCtD
Rifabutin—Thrombocytopenia—Etoposide—testicular cancer	0.0014	0.00209	CcSEcCtD
Rifabutin—Eosinophilia—Epirubicin—testicular cancer	0.00139	0.00208	CcSEcCtD
Rifabutin—Dyspnoea—Cisplatin—testicular cancer	0.00139	0.00208	CcSEcCtD
Rifabutin—Skin disorder—Etoposide—testicular cancer	0.00138	0.00207	CcSEcCtD
Rifabutin—Anorexia—Etoposide—testicular cancer	0.00136	0.00204	CcSEcCtD
Rifabutin—Aspartate aminotransferase increased—Doxorubicin—testicular cancer	0.00135	0.00203	CcSEcCtD
Rifabutin—Decreased appetite—Cisplatin—testicular cancer	0.00135	0.00203	CcSEcCtD
Rifabutin—Diarrhoea—Dactinomycin—testicular cancer	0.00135	0.00202	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Cisplatin—testicular cancer	0.00134	0.00201	CcSEcCtD
Rifabutin—Vomiting—Bleomycin—testicular cancer	0.00134	0.00201	CcSEcCtD
Rifabutin—Pancytopenia—Epirubicin—testicular cancer	0.00133	0.002	CcSEcCtD
Rifabutin—Rash—Bleomycin—testicular cancer	0.00133	0.00199	CcSEcCtD
Rifabutin—Pain—Cisplatin—testicular cancer	0.00133	0.00199	CcSEcCtD
Rifabutin—Dermatitis—Bleomycin—testicular cancer	0.00133	0.00199	CcSEcCtD
Rifabutin—Hypersensitivity—Ifosfamide—testicular cancer	0.00133	0.00199	CcSEcCtD
Rifabutin—Alanine aminotransferase increased—Doxorubicin—testicular cancer	0.00133	0.00199	CcSEcCtD
Rifabutin—Neutropenia—Epirubicin—testicular cancer	0.00131	0.00197	CcSEcCtD
Rifabutin—Asthenia—Ifosfamide—testicular cancer	0.00129	0.00194	CcSEcCtD
Rifabutin—Eosinophilia—Doxorubicin—testicular cancer	0.00129	0.00193	CcSEcCtD
Rifabutin—Feeling abnormal—Cisplatin—testicular cancer	0.00128	0.00192	CcSEcCtD
Rifabutin—Paraesthesia—Etoposide—testicular cancer	0.00128	0.00192	CcSEcCtD
Rifabutin—Pruritus—Ifosfamide—testicular cancer	0.00128	0.00191	CcSEcCtD
Rifabutin—Dyspnoea—Etoposide—testicular cancer	0.00127	0.0019	CcSEcCtD
Rifabutin—Hepatobiliary disease—Methotrexate—testicular cancer	0.00127	0.0019	CcSEcCtD
Rifabutin—Nausea—Bleomycin—testicular cancer	0.00125	0.00188	CcSEcCtD
Rifabutin—Vomiting—Dactinomycin—testicular cancer	0.00125	0.00188	CcSEcCtD
Rifabutin—Agranulocytosis—Methotrexate—testicular cancer	0.00125	0.00187	CcSEcCtD
Rifabutin—Rash—Dactinomycin—testicular cancer	0.00124	0.00186	CcSEcCtD
Rifabutin—Decreased appetite—Etoposide—testicular cancer	0.00124	0.00186	CcSEcCtD
Rifabutin—Diarrhoea—Ifosfamide—testicular cancer	0.00123	0.00185	CcSEcCtD
Rifabutin—Pancytopenia—Doxorubicin—testicular cancer	0.00123	0.00185	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Etoposide—testicular cancer	0.00123	0.00184	CcSEcCtD
Rifabutin—Body temperature increased—Cisplatin—testicular cancer	0.00123	0.00184	CcSEcCtD
Rifabutin—Jaundice—Epirubicin—testicular cancer	0.00122	0.00183	CcSEcCtD
Rifabutin—Pain—Etoposide—testicular cancer	0.00122	0.00183	CcSEcCtD
Rifabutin—Neutropenia—Doxorubicin—testicular cancer	0.00122	0.00182	CcSEcCtD
Rifabutin—Hepatitis—Methotrexate—testicular cancer	0.0012	0.0018	CcSEcCtD
Rifabutin—Hepatobiliary disease—Epirubicin—testicular cancer	0.00118	0.00178	CcSEcCtD
Rifabutin—Feeling abnormal—Etoposide—testicular cancer	0.00117	0.00176	CcSEcCtD
Rifabutin—Nausea—Dactinomycin—testicular cancer	0.00117	0.00175	CcSEcCtD
Rifabutin—Agranulocytosis—Epirubicin—testicular cancer	0.00117	0.00175	CcSEcCtD
Rifabutin—Gastrointestinal pain—Etoposide—testicular cancer	0.00117	0.00175	CcSEcCtD
Rifabutin—Vomiting—Ifosfamide—testicular cancer	0.00115	0.00172	CcSEcCtD
Rifabutin—Hypersensitivity—Cisplatin—testicular cancer	0.00115	0.00172	CcSEcCtD
Rifabutin—Rash—Ifosfamide—testicular cancer	0.00114	0.0017	CcSEcCtD
Rifabutin—Dermatitis—Ifosfamide—testicular cancer	0.00114	0.0017	CcSEcCtD
Rifabutin—Jaundice—Doxorubicin—testicular cancer	0.00113	0.00169	CcSEcCtD
Rifabutin—Body temperature increased—Etoposide—testicular cancer	0.00113	0.00169	CcSEcCtD
Rifabutin—Abdominal pain—Etoposide—testicular cancer	0.00113	0.00169	CcSEcCtD
Rifabutin—Hepatitis—Epirubicin—testicular cancer	0.00112	0.00169	CcSEcCtD
Rifabutin—Eye disorder—Methotrexate—testicular cancer	0.00112	0.00168	CcSEcCtD
Rifabutin—Asthenia—Cisplatin—testicular cancer	0.00112	0.00167	CcSEcCtD
Rifabutin—Connective tissue disorder—Epirubicin—testicular cancer	0.00111	0.00166	CcSEcCtD
Rifabutin—Hepatobiliary disease—Doxorubicin—testicular cancer	0.0011	0.00164	CcSEcCtD
Rifabutin—Immune system disorder—Methotrexate—testicular cancer	0.00109	0.00163	CcSEcCtD
Rifabutin—Agranulocytosis—Doxorubicin—testicular cancer	0.00108	0.00162	CcSEcCtD
Rifabutin—Nausea—Ifosfamide—testicular cancer	0.00107	0.00161	CcSEcCtD
Rifabutin—Diarrhoea—Cisplatin—testicular cancer	0.00106	0.0016	CcSEcCtD
Rifabutin—Eye disorder—Epirubicin—testicular cancer	0.00105	0.00157	CcSEcCtD
Rifabutin—Hypersensitivity—Etoposide—testicular cancer	0.00105	0.00157	CcSEcCtD
Rifabutin—Hepatitis—Doxorubicin—testicular cancer	0.00104	0.00156	CcSEcCtD
Rifabutin—Dysgeusia—Methotrexate—testicular cancer	0.00102	0.00153	CcSEcCtD
Rifabutin—Asthenia—Etoposide—testicular cancer	0.00102	0.00153	CcSEcCtD
Rifabutin—Connective tissue disorder—Doxorubicin—testicular cancer	0.00102	0.00153	CcSEcCtD
Rifabutin—Immune system disorder—Epirubicin—testicular cancer	0.00102	0.00152	CcSEcCtD
Rifabutin—Pruritus—Etoposide—testicular cancer	0.00101	0.00151	CcSEcCtD
Rifabutin—Vomiting—Cisplatin—testicular cancer	0.000989	0.00148	CcSEcCtD
Rifabutin—Rash—Cisplatin—testicular cancer	0.000981	0.00147	CcSEcCtD
Rifabutin—Dermatitis—Cisplatin—testicular cancer	0.00098	0.00147	CcSEcCtD
Rifabutin—Diarrhoea—Etoposide—testicular cancer	0.000975	0.00146	CcSEcCtD
Rifabutin—Eye disorder—Doxorubicin—testicular cancer	0.000972	0.00146	CcSEcCtD
Rifabutin—Anaemia—Methotrexate—testicular cancer	0.000967	0.00145	CcSEcCtD
Rifabutin—Flatulence—Epirubicin—testicular cancer	0.000965	0.00145	CcSEcCtD
Rifabutin—Dysgeusia—Epirubicin—testicular cancer	0.000959	0.00144	CcSEcCtD
Rifabutin—Immune system disorder—Doxorubicin—testicular cancer	0.00094	0.00141	CcSEcCtD
Rifabutin—Leukopenia—Methotrexate—testicular cancer	0.000936	0.0014	CcSEcCtD
Rifabutin—Nausea—Cisplatin—testicular cancer	0.000924	0.00138	CcSEcCtD
Rifabutin—Convulsion—Methotrexate—testicular cancer	0.000906	0.00136	CcSEcCtD
Rifabutin—Vomiting—Etoposide—testicular cancer	0.000906	0.00136	CcSEcCtD
Rifabutin—Anaemia—Epirubicin—testicular cancer	0.000905	0.00136	CcSEcCtD
Rifabutin—Rash—Etoposide—testicular cancer	0.000899	0.00135	CcSEcCtD
Rifabutin—Dermatitis—Etoposide—testicular cancer	0.000898	0.00135	CcSEcCtD
Rifabutin—Headache—Etoposide—testicular cancer	0.000893	0.00134	CcSEcCtD
Rifabutin—Flatulence—Doxorubicin—testicular cancer	0.000893	0.00134	CcSEcCtD
Rifabutin—Arthralgia—Methotrexate—testicular cancer	0.000891	0.00133	CcSEcCtD
Rifabutin—Myalgia—Methotrexate—testicular cancer	0.000891	0.00133	CcSEcCtD
Rifabutin—Chest pain—Methotrexate—testicular cancer	0.000891	0.00133	CcSEcCtD
Rifabutin—Dysgeusia—Doxorubicin—testicular cancer	0.000887	0.00133	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000884	0.00133	CcSEcCtD
Rifabutin—Leukopenia—Epirubicin—testicular cancer	0.000876	0.00131	CcSEcCtD
Rifabutin—Confusional state—Methotrexate—testicular cancer	0.000861	0.00129	CcSEcCtD
Rifabutin—Convulsion—Epirubicin—testicular cancer	0.000848	0.00127	CcSEcCtD
Rifabutin—Nausea—Etoposide—testicular cancer	0.000847	0.00127	CcSEcCtD
Rifabutin—Anaemia—Doxorubicin—testicular cancer	0.000837	0.00125	CcSEcCtD
Rifabutin—Thrombocytopenia—Methotrexate—testicular cancer	0.000836	0.00125	CcSEcCtD
Rifabutin—Myalgia—Epirubicin—testicular cancer	0.000833	0.00125	CcSEcCtD
Rifabutin—Chest pain—Epirubicin—testicular cancer	0.000833	0.00125	CcSEcCtD
Rifabutin—Arthralgia—Epirubicin—testicular cancer	0.000833	0.00125	CcSEcCtD
Rifabutin—Skin disorder—Methotrexate—testicular cancer	0.000829	0.00124	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000828	0.00124	CcSEcCtD
Rifabutin—Anorexia—Methotrexate—testicular cancer	0.000814	0.00122	CcSEcCtD
Rifabutin—Leukopenia—Doxorubicin—testicular cancer	0.000811	0.00121	CcSEcCtD
Rifabutin—Confusional state—Epirubicin—testicular cancer	0.000806	0.00121	CcSEcCtD
Rifabutin—Shock—Epirubicin—testicular cancer	0.000786	0.00118	CcSEcCtD
Rifabutin—Convulsion—Doxorubicin—testicular cancer	0.000785	0.00118	CcSEcCtD
Rifabutin—Thrombocytopenia—Epirubicin—testicular cancer	0.000782	0.00117	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000778	0.00117	CcSEcCtD
Rifabutin—Skin disorder—Epirubicin—testicular cancer	0.000776	0.00116	CcSEcCtD
Rifabutin—Insomnia—Methotrexate—testicular cancer	0.000772	0.00116	CcSEcCtD
Rifabutin—Arthralgia—Doxorubicin—testicular cancer	0.000771	0.00116	CcSEcCtD
Rifabutin—Chest pain—Doxorubicin—testicular cancer	0.000771	0.00116	CcSEcCtD
Rifabutin—Myalgia—Doxorubicin—testicular cancer	0.000771	0.00116	CcSEcCtD
Rifabutin—Paraesthesia—Methotrexate—testicular cancer	0.000767	0.00115	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000766	0.00115	CcSEcCtD
Rifabutin—Anorexia—Epirubicin—testicular cancer	0.000762	0.00114	CcSEcCtD
Rifabutin—Dyspnoea—Methotrexate—testicular cancer	0.000761	0.00114	CcSEcCtD
Rifabutin—Dyspepsia—Methotrexate—testicular cancer	0.000752	0.00113	CcSEcCtD
Rifabutin—Confusional state—Doxorubicin—testicular cancer	0.000745	0.00112	CcSEcCtD
Rifabutin—Decreased appetite—Methotrexate—testicular cancer	0.000742	0.00111	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000737	0.0011	CcSEcCtD
Rifabutin—Pain—Methotrexate—testicular cancer	0.00073	0.00109	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000728	0.00109	CcSEcCtD
Rifabutin—Shock—Doxorubicin—testicular cancer	0.000727	0.00109	CcSEcCtD
Rifabutin—Thrombocytopenia—Doxorubicin—testicular cancer	0.000724	0.00108	CcSEcCtD
Rifabutin—Insomnia—Epirubicin—testicular cancer	0.000723	0.00108	CcSEcCtD
Rifabutin—Skin disorder—Doxorubicin—testicular cancer	0.000718	0.00108	CcSEcCtD
Rifabutin—Paraesthesia—Epirubicin—testicular cancer	0.000717	0.00107	CcSEcCtD
Rifabutin—Dyspnoea—Epirubicin—testicular cancer	0.000712	0.00107	CcSEcCtD
Rifabutin—Anorexia—Doxorubicin—testicular cancer	0.000705	0.00106	CcSEcCtD
Rifabutin—Feeling abnormal—Methotrexate—testicular cancer	0.000704	0.00105	CcSEcCtD
Rifabutin—Dyspepsia—Epirubicin—testicular cancer	0.000703	0.00105	CcSEcCtD
Rifabutin—Gastrointestinal pain—Methotrexate—testicular cancer	0.000698	0.00105	CcSEcCtD
Rifabutin—Decreased appetite—Epirubicin—testicular cancer	0.000695	0.00104	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Epirubicin—testicular cancer	0.00069	0.00103	CcSEcCtD
Rifabutin—Pain—Epirubicin—testicular cancer	0.000683	0.00102	CcSEcCtD
Rifabutin—Abdominal pain—Methotrexate—testicular cancer	0.000675	0.00101	CcSEcCtD
Rifabutin—Body temperature increased—Methotrexate—testicular cancer	0.000675	0.00101	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000674	0.00101	CcSEcCtD
Rifabutin—Insomnia—Doxorubicin—testicular cancer	0.000669	0.001	CcSEcCtD
Rifabutin—Paraesthesia—Doxorubicin—testicular cancer	0.000664	0.000995	CcSEcCtD
Rifabutin—Dyspnoea—Doxorubicin—testicular cancer	0.000659	0.000988	CcSEcCtD
Rifabutin—Feeling abnormal—Epirubicin—testicular cancer	0.000658	0.000987	CcSEcCtD
Rifabutin—Gastrointestinal pain—Epirubicin—testicular cancer	0.000653	0.000979	CcSEcCtD
Rifabutin—Dyspepsia—Doxorubicin—testicular cancer	0.000651	0.000975	CcSEcCtD
Rifabutin—Decreased appetite—Doxorubicin—testicular cancer	0.000643	0.000963	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000638	0.000956	CcSEcCtD
Rifabutin—Pain—Doxorubicin—testicular cancer	0.000632	0.000947	CcSEcCtD
Rifabutin—Abdominal pain—Epirubicin—testicular cancer	0.000632	0.000946	CcSEcCtD
Rifabutin—Body temperature increased—Epirubicin—testicular cancer	0.000632	0.000946	CcSEcCtD
Rifabutin—Hypersensitivity—Methotrexate—testicular cancer	0.000629	0.000942	CcSEcCtD
Rifabutin—Asthenia—Methotrexate—testicular cancer	0.000613	0.000918	CcSEcCtD
Rifabutin—Feeling abnormal—Doxorubicin—testicular cancer	0.000609	0.000913	CcSEcCtD
Rifabutin—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000604	0.000906	CcSEcCtD
Rifabutin—Pruritus—Methotrexate—testicular cancer	0.000604	0.000905	CcSEcCtD
Rifabutin—Hypersensitivity—Epirubicin—testicular cancer	0.000589	0.000882	CcSEcCtD
Rifabutin—Abdominal pain—Doxorubicin—testicular cancer	0.000584	0.000876	CcSEcCtD
Rifabutin—Body temperature increased—Doxorubicin—testicular cancer	0.000584	0.000876	CcSEcCtD
Rifabutin—Diarrhoea—Methotrexate—testicular cancer	0.000584	0.000875	CcSEcCtD
Rifabutin—Asthenia—Epirubicin—testicular cancer	0.000573	0.000859	CcSEcCtD
Rifabutin—Pruritus—Epirubicin—testicular cancer	0.000565	0.000847	CcSEcCtD
Rifabutin—Diarrhoea—Epirubicin—testicular cancer	0.000547	0.000819	CcSEcCtD
Rifabutin—Hypersensitivity—Doxorubicin—testicular cancer	0.000545	0.000816	CcSEcCtD
Rifabutin—Vomiting—Methotrexate—testicular cancer	0.000543	0.000813	CcSEcCtD
Rifabutin—Rash—Methotrexate—testicular cancer	0.000538	0.000807	CcSEcCtD
Rifabutin—Dermatitis—Methotrexate—testicular cancer	0.000538	0.000806	CcSEcCtD
Rifabutin—Headache—Methotrexate—testicular cancer	0.000535	0.000801	CcSEcCtD
Rifabutin—Asthenia—Doxorubicin—testicular cancer	0.00053	0.000795	CcSEcCtD
Rifabutin—Pruritus—Doxorubicin—testicular cancer	0.000523	0.000784	CcSEcCtD
Rifabutin—Vomiting—Epirubicin—testicular cancer	0.000508	0.000761	CcSEcCtD
Rifabutin—Nausea—Methotrexate—testicular cancer	0.000507	0.00076	CcSEcCtD
Rifabutin—Diarrhoea—Doxorubicin—testicular cancer	0.000506	0.000758	CcSEcCtD
Rifabutin—Rash—Epirubicin—testicular cancer	0.000504	0.000755	CcSEcCtD
Rifabutin—Dermatitis—Epirubicin—testicular cancer	0.000503	0.000754	CcSEcCtD
Rifabutin—Headache—Epirubicin—testicular cancer	0.000501	0.00075	CcSEcCtD
Rifabutin—Nausea—Epirubicin—testicular cancer	0.000475	0.000711	CcSEcCtD
Rifabutin—Vomiting—Doxorubicin—testicular cancer	0.00047	0.000704	CcSEcCtD
Rifabutin—Rash—Doxorubicin—testicular cancer	0.000466	0.000698	CcSEcCtD
Rifabutin—Dermatitis—Doxorubicin—testicular cancer	0.000466	0.000698	CcSEcCtD
Rifabutin—Headache—Doxorubicin—testicular cancer	0.000463	0.000694	CcSEcCtD
Rifabutin—Nausea—Doxorubicin—testicular cancer	0.000439	0.000658	CcSEcCtD
